Form SUPPL - Voluntary Supplemental Material by Foreign Issuers [Section 11(a)]:
SEC Accession No. 0001193125-13-065215
Filing Date
2013-02-19
Accepted
2013-02-19 16:13:09
Documents
5
Effectiveness Date
2013-02-19

Document Format Files

Seq Description Document Type Size
1 SUPPLEMENT d486450dsuppl.htm SUPPL 496994
2 GRAPHIC g483813g55t09.jpg GRAPHIC 55197
3 GRAPHIC g483813g72m57.jpg GRAPHIC 13114
4 GRAPHIC g483813g89q14.jpg GRAPHIC 88455
5 GRAPHIC g486450g72m57.jpg GRAPHIC 13114
  Complete submission text file 0001193125-13-065215.txt   732649
Mailing Address 210 - 1167 KENSINGTON CRES NW CALGARY A0 T2N 1X7
Business Address 1167 KENSINGTON CRES NW SUITE 210 CALGARY ALBERTA CANADA T2N 1X7 ALBERTA CANADA A0 00000 4036707380
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: SUPPL | Act: 98 | File No.: 333-182260 | Film No.: 13623568
SIC: 2834 Pharmaceutical Preparations